Skip to main content

Table 1 Patient and tumor characteristics

From: The ability of whole-body SUVmax in F-18 FDG PET/CT to predict suboptimal cytoreduction during primary debulking surgery for advanced ovarian cancer

Variable Median (range) or Number (%)
Age (years) 58.0 (37–74)
FIGO stage
 IIIC 37 (72.5)
 IV 14 (27.5)
Tumor grade
 1 1 (2.0)
 2 8 (15.7)
 3 42 (82.4)
Histology
 Serous 40 (78.4)
 Endometroid 5 (9.8)
 Clear 2 (3.9)
 Mucinous 1 (2.0)
 Others 3 (5.9)
Preoperative CA 125 (U/mL) 573.7 (38–6000)
Ascites
  < 500 mL 11 (21.6)
  >  500 mL 40 (78.4)
ECOG PS
 0 8 (15.7)
 1 31 (60.8)
 2 12 (23.6)
  1. FIGO International Federation of Gynecology and Obstetrics, ECOG PS Eastern cooperative oncology group performance status